【谷歌新闻非洲】Why Lilly and Novo are betting on amylin to power a new wave of obesi…

aipl1234

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s - cnbc.com

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s  cnbc.comExperimental Lilly combination drug tops Zepbound in weight-loss trial  reuters.com‘Godzilla’ of weight-loss drugs could provide other important health benefits  The GuardianBlockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs  Scientific AmericanLilly’s Next-Gen Obesity Drug Helps People Lose Even More Weight in Study  WSJ

本文为英文资讯，中文内容由机器翻译生成，仅供参考。详情请阅读文末原文。

—— 资讯转载说明 ——
本文由非洲论坛根据公开信息整理，供中国读者查阅，不代表本站立场。
来源：Google News Africa (https://news.google.com/)
原文链接：https://news.google.com/rss/articles/CBMid0FVX3lxTE9nLU5qVURCR0h4SmxQUjdDYXdPYUtUa3VzUzdGM3d1MWlEY1JldnpuekktRkFUOHVBbTZtM3BEQWVrNmg3U1J0TVdUSmp5Zmg0ZXZLSWZXTm1udlBxak9QaDMxV2h1QlJybXVnS3NJYjJUdHNBZnlv0gF8QVVfeXFMTWVtbmp4Rmx2aWF1ZFVheklrLVhPdV9KYUlNUTR1NDM0U3kyQndmcVQyWnV5VTdEU29aRmgtMFpJbWc4RUZSWmlOZV9kb3d4M3I1Z01CdVNSQkx0ZHJpekEySUR5OTA3V2pjZzJrVFN4Ql9IVkoyNFhmMHlSSA?oc=5
转载请遵守原发布方版权与引用规定。